Who
Ambaw Bellete
President and COO
Company insider
Files Form 4 as: President and COO, CG Oncology.
In numbers
- Trades disclosed
- 4
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 4 Oct 2024
- Last trade
- 15 Apr 2026
- Last filed
- 16 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Apr 2026filed 16 Apr 2026 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —107,508 at $0.00 | filing |
| 15 Apr 2026filed 16 Apr 2026 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —107,508 at $0.00 | filing |
| 15 Apr 2025filed 16 Apr 2025 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —284,816 at $0.00 | filing |
| 4 Oct 2024filed 7 Oct 2024 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —175,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.